Healthscope has unanimously recommended shareholders accept an offer by a US consortium of $6.26 a share to buy the company." />

Healthscope poised to accept offer from TPG and Carlyle

By David Binning
Tuesday, 20 July, 2010

The board of private Australian healthcare provider Healthscope has unanimously recommended shareholders accept an offer by a US consortium of $6.26 a share to buy the company.

Texas Pacific Group (TPG) and the Carlyle Group are two of the world’s largest private equity firms, together managing over $US135 billion in equity capital. Their offer follows a formal evaluation process between the parties and values Healthscope at $2.7 billion, a 39 percent premium on the company’s closing price of $4.50 the day before the offer was made on May 13 this year.

The consortium had earlier confirmed that it planned to retain Healthscope managing director Bruce Dixon along with other senior managers.

With 44 private hospitals spread throughout every Australian state and territory, Healthscope is the country’s second largest private healthcare provider behind Ramsay Health.

Healthscope shares were up one cent to $5.95 by early afternoon trade.

Related News

Neurosensing/neurostimulation implants session to be held on Monday

On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...

Archer completes potassium sensing alpha prototype

Quantum technology company Archer Materials Limited has developed an early Biochip prototype...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd